Scott Burrows Insider Trades & Stock Holdings

Chief Financial Officer · Spyre Therapeutics, Inc. · Latest filing Jun 25, 2026

Scott Burrows, Chief Financial Officer at Spyre Therapeutics, Inc. has 2 Form 4 trades on file since Jun 25, 2026. Latest filing: disposed of 15K shares of $SYRE on Jun 25, 2026.

Trades on file

2

Open-market bought

$0

Open-market sold

$0

Net open-market

$0

Latest filing

Jun 25, 2026

All insider trades by Scott Burrows

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 25, 2026	$SYRE	Sell (Option exercise)	15K	$0	—			-2.3%	+12.8%		Chief Financial Officer		Read
Jun 25, 2026	$SYRE	Buy (Option exercise)	15K	$14.50	$217.50K			-2.3%	+12.8%		Chief Financial Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Scott Burrows traded

• $SYRE

Frequently asked questions

What was Scott Burrows's latest insider trade?

disposed of 15K shares of $SYRE on Jun 25, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.